| Multiple Sclerosis |
1 |
1 |
| Monoclonal Antibody |
0 |
0.96 |
| Antineoplastic Drug |
0 |
0.94 |
| Vaccines |
0 |
0.92 |
| Biologic Therapy |
0 |
0.9 |
| COVID-19 Vaccine |
0 |
0.99 |
| Hospital |
0 |
0.24 |
| Immunization |
0 |
0.24 |
| COVID-19 |
0 |
0.19 |
| Clinical Guidelines |
0 |
0.16 |
| Arthritis |
0 |
0.08 |
| Cancer |
0 |
0.08 |
| Generics |
0 |
0.08 |
| Immunoglobulin G (IgG) |
0 |
0.08 |
| Multiple Sclerosis Relapse |
0 |
0.08 |
| Multiple Sclerosis Treatment |
0 |
0.08 |
| Ohio |
0 |
0.08 |
| Pandemic |
0 |
0.08 |
| Remission |
0 |
0.08 |
| Severe Acute Respiratory Syndrome |
0 |
0.08 |
| T-Lymphocyte |
0 |
0.08 |
| Rheumatoid Arthritis |
0 |
0.07 |
| Acute Respiratory Distress Syndrome |
0 |
0.05 |